Selenium, zinc, and copper plasma levels in patients with schizophrenia: relationship with metabolic risk factors. (Q51332386)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24150923%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

title

Selenium, zinc, and copper plasma levels in patients with schizophrenia: relationship with metabolic risk factors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24150923%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24150923%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

author name string

Brižita Dorđević

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24150923%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Srđan Milovanović

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24150923%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Sandra Škrivanj

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24150923%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Zoran Pavlović

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24150923%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Aleksandra Stefanović

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24150923%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Jelena Kotur-Stevuljević

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24150923%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

publication date

24 October 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24150923%20AND%20SRC:MED&resulttype=core&format=json

Biological Trace Element Research

28 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24150923%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

volume

156

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24150923%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

page(s)

22-28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24150923%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

issue

1-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24150923%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s12011-013-9842-1

28 February 2020

exact match

0 references

cites work

Life expectancy and cardiovascular mortality in persons with schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS12011-013-9842-1

Schizophrenia: medical illness, mortality, and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-013-9842-1

Cardiovascular disease and diabetes in people with severe mental illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-013-9842-1

The prevalence and mechanisms of metabolic syndrome in schizophrenia: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-013-9842-1

Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-013-9842-1

Oxidative stress and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-013-9842-1

Trace elements in regulation of NF-kappaB activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-013-9842-1

The metabolic syndrome and antioxidant concentrations: findings from the Third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-013-9842-1

Gender differences in copper, zinc and selenium status in diabetic-free metabolic syndrome European population - the IMMIDIET study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-013-9842-1

Antioxidants, trace elements and metabolic syndrome in elderly subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-013-9842-1

Plasma copper, zinc, and selenium levels and correlates with metabolic syndrome components of lebanese adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-013-9842-1

The metabolic syndrome--a new worldwide definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-013-9842-1

Transformations, means, and confidence intervals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-013-9842-1

International consensus study of antipsychotic dosing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-013-9842-1

Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-013-9842-1

Metabolic risk during antipsychotic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-013-9842-1

Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders--a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-013-9842-1

Plasma manganese, selenium, zinc, copper, and iron concentrations in patients with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-013-9842-1

The influence of some antipsychotics on erythrocyte magnesium and plasma magnesium, calcium, copper and zinc in patients with paranoid schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-013-9842-1

Trace metals in neuropsychiatry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-013-9842-1

The copper hypothesis of schizophrenia: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-013-9842-1

Zinc: the brain's dark horse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-013-9842-1

Selenium and human health.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-013-9842-1

Selenium deficiency in Yugoslavia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-013-9842-1

Low blood selenium concentrations in schizophrenic patients on clozapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-013-9842-1

Selenium concentrations in blood and serum from patients with mental diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-013-9842-1

Serum selenium concentration is associated with metabolic factors in the elderly: a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-013-9842-1

Higher selenium status is associated with adverse blood lipid profile in British adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-013-9842-1

Regulation of selenoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-013-9842-1

Selenium in human health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-013-9842-1

High selenium intake and increased diabetes risk: experimental evidence for interplay between selenium and carbohydrate metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-013-9842-1

Oxidative stress is associated with the number of components of metabolic syndrome: LIPGENE study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12011-013-9842-1